Skip to main content
S 2295 112th Congress Senate Health Drug safety, medical device, and laboratory regulation Prescription drugs

Patient Safety and Generic Labeling Improvement Act

Introduced: April 18, 2012 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 112th Congress ended
It never became law before the 112th Congress (2011–2012) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 18, 2012
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2498)
Apr 18, 2012
Sponsor introductory remarks on measure. (CR S2497-2498, S2499-2500)
Apr 18, 2012
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Patient Safety and Generic Labeling Improvement Act - Amends the Federal Food, Drug, and Cosmetic Act to allow the holder of an approved abbreviated new drug application (generic drug approval) to change the labeling of a drug so approved in the same manner authorized by regulation for the holder of an approved new drug application.

Allows conforming changes to be ordered to the labeling of the equivalent listed drug and each drug approved under the abbreviated new drug application process that corresponds to such listed drug.

What's happening now April 18, 2012

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2498)

 Related & companion bills 1
  • HR 4384 Related bill Patient Safety and Drug Labeling Improvement Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 3
All 3 Democratic 3
D
Blumenthal, Richard
Connecticut · Apr 18, 2012
 D
Coons, Christopher A.
Delaware · Apr 18, 2012
 D
Whitehouse, Sheldon
Rhode Island · Apr 18, 2012
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2295: Patient Safety and Generic Labeling Improvement Act. 112th Congress. Open America. https://openamerica.io/bill/112-S-2295/
MLA
"S. 2295: Patient Safety and Generic Labeling Improvement Act." 112th Congress, 2026, Open America, https://openamerica.io/bill/112-S-2295/.
Bluebook (legal)
S. 2295, 112th Cong. (2026), https://openamerica.io/bill/112-S-2295/.
Markdown link
[S. 2295: Patient Safety and Generic Labeling Improvement Act](https://openamerica.io/bill/112-S-2295/)
Report a problem